NovaBiotics Phase 1 Study of Lynovex

NovaBiotics and the cystic fibrosis (CF) teams at Aberdeen Royal Infirmary are investigating the microbiological and mucolytic potential of Lynovex®, NovaBiotics’ drug candidate which is being developed as a novel treatment for cystic fibrosis. The collaboration with the CF clinical … Continued